BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 204442)

  • 1. Uptake by bone of pyrophosphate, diphosphonates and their technetium derivatives.
    Bisaz S; Jung A; Fleisch H
    Clin Sci Mol Med; 1978 Mar; 54(3):265-72. PubMed ID: 204442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R; Neumann R; Goldsmith SJ
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 6. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The radiation dose to children bone scintigraphy with 99mTc-phosphate compounds (author's transl)].
    Eissner D; Wolf R
    Rofo; 1980 Mar; 132(3):331-5. PubMed ID: 6253368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
    Schümichen C; Hohloch M; Hoffmann G
    Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
    Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
    J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extraction from the blood of phosphate compounds by canine bone.
    Hughes SP; Wahner HW; Kelly PJ; Davies DR
    Nuklearmedizin; 1979 Jun; 18(3):137-41. PubMed ID: 228254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comment on "Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism".
    Caniggia A; Vattimo A
    Calcif Tissue Int; 1983; 35(2):261. PubMed ID: 6850407
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Coupal JJ
    Calcif Tissue Int; 1981; 33(5):555. PubMed ID: 6797708
    [No Abstract]   [Full Text] [Related]  

  • 14. [Local blood flow and bone uptake of methylene-diphosphonate-technetium-99m. 2].
    Vattimo A; Martini G
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1614-7. PubMed ID: 6230088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical comparison of the kinetics of 99mTc pyrophosphate and 99mTc methylene diphosphonate (author's transl)].
    Casara D; Cimitan M; Zorat P; Calzavara F
    Radiol Med; 1979; 65(1-2):67-70. PubMed ID: 223200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative quality control of 99mTc-Pyrophosphate and 99mTc-diphosphonate radiopharmaceuticals.
    Jovanović V; Maksin T; Rastovac M; Bzenić J
    Eur J Nucl Med; 1983; 8(4):179-82. PubMed ID: 6861787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of the distribution of 99mTc-labelled ethylene hydroxy diphosphonate in young rats.
    Rohlin M; Nosslin B
    Eur J Nucl Med; 1977 Jun; 2(2):113-5. PubMed ID: 891555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retention of 99mTc-diphosphonate in the bones and soft tissues of rats: distribution, time factors, the effect of age].
    Kapitola J; Kobos L; Jahoda I; Vilimovská D
    Sb Lek; 1987; 89(2-3):60-6. PubMed ID: 3589471
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution of 99Tcm-labelled phosphorus compounds, 45Ca and 85Sr in diphosphonate-treated rats.
    Rohlin M; Larsson A; Hammarström L
    Acta Radiol Ther Phys Biol; 1977 Dec; 16(6):513-24. PubMed ID: 607780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Caniggia A; Vattimo A
    Calcif Tissue Int; 1980; 30(1):5-13. PubMed ID: 6767533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.